COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

Russia In Vitro Fertilization (IVF) Market Expected to Reach $641 Million by 2022


quote Fertility clinics and hospitals collectively contributed about three-fourths of the market revenue in 2014. This is attributed to their crucial role in providing technologically advanced IVF treatment to couples seeking assistance for infertility treatment. quote

Sriram Radhakrishnan
Team Lead, Healthcare at AMR

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, "Russia In Vitro Fertilization Market by End User, Cycle Type, Type, Drug, and Mode of Administration: Opportunity Analysis and Industry Forecast, 2014-2022," the IVF market size inRussia was valued at $398 million in 2015, and is projected to reach $641 million by 2022, growing at a CAGR of 7.0% from 2016 to 2022. Non-assisted IVF cycles are projected to witness the highest growth rate from 2016 to 2022.

Access Full Summary at: https://www.alliedmarketresearch.com/russia-in-vitro-fertilization-IVF-market

In vitro fertilization (IVF) is an assisted reproductive technology (ART) that involves extraction of eggs, sample retrieval of sperm cells, followed by manual combination of an egg and sperm in laboratory settings to form an embryo. The embryo(s) is then transferred to the womans uterus for further gestation.

The Russia IVF market is driven by increase in incidence of infertility cases, emergent trend of delayed pregnancies among women, technological advancements in IVF procedures, and rise in gamete donation. However, insufficient reimbursement policies related to IVF treatment are anticipated to impede this growth. Moreover, growth in interest of single parents and same-sex couples to experience parenthood through ART, especially IVF, is expected to present various opportunities for market development.

The fertility clinics segment accounted for the highest share of the Russia IVF end user market in 2015, owing to the availability of wide range of fertility treatments under a single roof and applicable government reimbursements. The donor egg IVF cycle type segment is anticipated to witness the highest growth rate from 2016 to 2022. However, the fresh cycle (non-donor) is projected to dominate the cycle type market.
At present, gonadotropins & gonadotropin-releasing hormones dominate the drug segment of the market, and is expected to grow at a CAGR of 6.5% during the forecast period. This is attributable to the effectiveness and safety of this drug to stimulate ovulation during an IVF procedure.

Key Findings of the Russia In Vitro Fertilization (IVF) Market:

  • The fertility clinics end-user segment is anticipated to grow at the highest CAGR from 2016 to 2022 in terms of value as well as volume.
  • The fresh IVF cycle (non-donor) cycle type segment generated the highest revenue in 2015, and is expected to continue its dominance in the near future.
  • ICSI assisted IVF cycles dominated the Russia in vitro fertilizationmarket, and are projected to grow at a CAGR of 6.4%.
  • Donor egg IVF cycle type is expected to witness the highest growth rate in terms of value as well as volume during the forecast period.

The major companies profiled in the report include Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of the Reproductive Medicines).


Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com


For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote In Vitro Fertilization (IVF) Market in Russia by End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles), Type (Non-intracytoplasmic Sperm Injection (ICSI) IVF Cycles, and ICSI-Assisted IVF Cycles), Drug (Clomiphene Citrate, Aromatase Inhibitors, Gonadotropins & Gonadotropin-releasing Hormone, Follicle-stimulating Hormone, Progesterone, and Others), and Mode of Administration (Oral, Injectable, and Vaginal) - Opportunity Analysis and Industry Forecast, 2014-2022 quote

View Report

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Russia In Vitro Fertilization (IVF) Market"
Purchase Enquiry